AMPA-Type Glutamate Receptors Associated With Vascular Smooth Muscle Cell Subpopulations in Atherosclerosis and Vascular Injury

Frontiers in Cardiovascular Medicine

Robert C. Wirka¹  Thomas Quertermous²  Alessandro L. Gallina³  Gabrielle Paulsson-Berne³  April S. Caravaca³  Laura Tarnawski³  Glykeria Karadimou³  Vladimir S. Shavva³  Anton Gisterå³  Stephen G. Malin³  Mohamad Youness⁴  Peder S. Olofsson⁵  Ljubica Matic⁶  Urszula Rykaczewska⁶  Mariette Lengquist⁶  Anton Razuvaev⁶ 

[1] Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, NC, United States;Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, United States;McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, United States;Division of Cardiovascular Medicine and Cardiovascular Institute, School of Medicine, Stanford University, California, CA, United States;Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden;Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden;Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium;Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden;Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, United States;Vascular Surgery, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden;

关键词: inflammation;    neuroscience;    neurotransmitter;    GluA1;    GluA2;    smooth muscle cells;    atherosclerosis;    glutamate;   

DOI  :  10.3389/fcvm.2021.655869

来源: Frontiers

【 授权许可】

CC BY